Russian IPF Registry: time of inclusion impacts patients’ status

S. Chikina (Moscow, Russian Federation), S. Avdeev (Moscow, Russian Federation), I. Tyurin (Moscow, Russian Federation), A. Cherniak (Moscow, Russian Federation), Z. Merzhoeva (Moscow, Russian Federation)

Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Session: Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Session type: E-poster session
Number: 1842

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Chikina (Moscow, Russian Federation), S. Avdeev (Moscow, Russian Federation), I. Tyurin (Moscow, Russian Federation), A. Cherniak (Moscow, Russian Federation), Z. Merzhoeva (Moscow, Russian Federation). Russian IPF Registry: time of inclusion impacts patients’ status. 1842

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Association of COPD stages and comorbidities in Italian general practices: The COMODHES study
Source: Annual Congress 2012 - COPD epidemiology
Year: 2012


Disease progression at 12 months does not predict future outcomes in IPF patients: Analysis from the Australian IPF Registry
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017

Phenotypes, treatable traits, GOLD groups and grades – how they predict mortality risk in COPD patients? (data from the Czech Multicenter Research Database of COPD)
Source: Virtual Congress 2020 – New tools for risk stratification of obstructive diseases
Year: 2020


Impact of the COVID-19 pandemic on the behaviour and health status of patients with COPD: results from the German COPD cohort COSYCONET
Source: ERJ Open Res, 7 (3) 00242-2021; 10.1183/23120541.00242-2021
Year: 2021



Health status and gender predict time to next exacerbation in patients with COPD
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008

Effect of COPD medications on exacerbation rates in a real-life COPD patient cohort - data from the Czech Multicenter Research Database of COPD.
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020


Health status predicts long-term outcomes in patients with chronic obstructive pulmonary disease (COPD): Pooled analysis of patient-level data from the COPD biomarker qualification consortium database
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015

Clinical characteristics and determinants of exacerbation in Japanese patients with COPD: Hokkaido COPD cohort study results
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012


CPOD and lung function parameters as predictors of mortality: Results from the Latin American PLATINO cohort study
Source: International Congress 2014 – Longitudinal studies of respiratory disease
Year: 2014


Clinical description of a population of Dutch IPF patients
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008


Survival estimates in European cystic fibrosis patients and the impact of socioeconomic factors: a retrospective registry cohort study
Source: Eur Respir J, 58 (3) 2002288; 10.1183/13993003.02288-2020
Year: 2021



Dual bronchodilation in real-life COPD management: analysis of patients’ characteristics enrolled in COPD Registry in Russia
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020


Differences in patient characteristics and associations with comorbid load in Dutch and Australian COPD patients
Source: International Congress 2016 – Latest insights into chronic care
Year: 2016

Disease characteristics and outcomes in a Swedish cohort of patients with pulmonary fibrosis (PF)
Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Year: 2018


Impact of age in the clinical expression of COPD in Greek patients
Source: Annual Congress 2009 - Quality of life and symptoms in COPD
Year: 2009


Health economics of COPD: First results of the new German COSYCONET cohort compared to population-based controls from KORA
Source: International Congress 2014 – Highlights in respiratory epidemiology
Year: 2014

Health status and utility for COPD patients: a questionnaire-based study
Source: Annual Congress 2007 - Managing COPD in primary care
Year: 2007


Health status comparison of patients with COPD throughout the world: the BOLD Initiative
Source: Eur Respir J 2006; 28: Suppl. 50, 450s
Year: 2006

Health status changes in Dutch regular care COPD patients classified per GOLD category
Source: International Congress 2018 – Primary care management of COPD
Year: 2018


Gender differences in health status in patients with COPD: baseline characteristics of a multi-centre intervention and characterisation study on Seretide (COSMIC)
Source: Eur Respir J 2002; 20: Suppl. 38, 262s
Year: 2002